Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T18701 |
SPDB-DM4
|
Others | Others |
SPDB-DM4 is a drug-linker conjugate designed for antibody-drug conjugate (ADC) applications, employing the maytansine-based payload DM4 (a tubulin inhibitor) connected through a SPDB linker. This compound demonstrates significant anti-tumor efficacy. | |||
T18730 |
sulfo-SPDB-DM4
|
Others | Others |
Sulfo-SPDB-DM4 is a drug-linker conjugate designed for antibody-drug conjugates (ADCs) that employs the maytansine-based payload (DM4, an antitubulin agent) connected through the sulfo-SPDB linker. | |||
T38682 |
Lys-Nε-SPDB-DM4
Lys-Nε-SPDB-DM4 |
||
Lys-Nε-SPDB-DM4 is a drug-linker conjugate composed of a potent a tubulin inhibitor DM4 and a linker Lys-Nε-SPDB to make antibody drug conjugate (ADC). | |||
T77907 |
Tusamitamab ravtansine
HuMAb2-3-SPDB-DM4,SAR-408701 |
||
Tusamitamab ravtansine (SAR-408701) 是一款针对CEACAM5的人源化单克隆抗体与DM4细胞毒性药物经活性分子连接而成的抗体-药物偶联物(ADC),专门靶向CEACAM5表达的肿瘤细胞。 | |||
T4346 |
SPDB
|
Others | Others |
SPDB 是一种可降解的 ADC 连接剂,可用于合成抗体偶联药物。它是一个与 DM4 偶联物相连的小片段,利用二硫键与抗体偶联。 |